arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

GLOBUS MEDICAL INC

GMED
$81.41 ▼ -5.69 (-6.53%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
62 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
74
Health
Good
Bullish
auto_awesome

Analytical Summary

GLOBUS MEDICAL INC shows strong fundamentals with top-quartile Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $11.0B
Dividend Yield —
Revenue Growth 5.9% ↘
Op. Margin 23.1% ↗
ROIC 3.1% ↗
FCF / Share $1.31 ↗
Trailing P/E 72.7x
Price / Book 2.3x
FCF Yield 1.6%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

62-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$789.61M
↑ +5.9% —
Net Income Profit after all expenses
$151.57M
↓ -25.3% —
Operating Margin Operating profit as % of sales
23.1%
↑ +16.7% 69th
FCF / Share Free cash flow per share
$1.31
↑ +8.7% —
trending_up

Bullish Indicators

  • Profit Margin (%)Profit Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↓
77
Returns ↑
73
Cash Quality ↓
69

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 17 years · 62 quarters